SUMMARY A hypobetalipoproteinaemic kindred is described in which the proband manifested the clinical and biochemical features of the homozygous state. Unlike the apparent complete absence of apolipoprotein B in the plasma of the five cases of homozygous hypobetalipoproteinaemia reported so far, we were able to demonstrate minute quantities of this protein (approximately 0 025% of normal) in the plasma of the proband. This finding suggests that the disorder may not result from a structural gene defect but may rather reflect a failure of secretion.
The homozygous state of the autosomal recessive condition abetalipoproteinaemia (ABLPR), and the autosomal dominant disorder hypobetalipoproteinaemia (HBLP), are both characterised by the apparent complete absence of apolipoprotein B (apoB) from the plasma.1 2 Homozygous HBLP is an extremely rare condition having been described in only five patients from four separate kindreds. [3] [4] [5] [6] Both ABLPR and homozygous HBLP manifest with similar plasma lipoprotein and lipid phenotypes and present with steatorrhoea, growth retardation, reduced plasma levels of the fat soluble vitamins, and anaemia characterised by abnormal red blood cell morphology, notably acanthocytosis.' 2 7 The two disorders are principally distinguished by the presence of normal levels of apoB and the apoB containing lipoproteins in the plasma of obligate heterozygotes for ABLPR, in contradistinction to the reduced levels present in hrterozygotes for HBLP, and by the relative absence of severe ocular and neuromuscular pathology in homozygous HBLP.
The distinctive modes of inheritance and the differing clinical presentation of the two syndromes imply that a different molecular defect underlies each disorder. In a recent report on a normotriglyceridaemic variant of ABLPR, in which the liver form of apoB (apoB-100) was absent, Malloy et a18 suggested that HBLP is probably the result of a structural gene defect. In this paper we report a fifth hypobetalipoproteinaemic kindred in which the proband presented with the clinical and biochemical Received for publication 2 ApoB and apoA in plasma from the proband and her mother were sought using standard methods of immunoelectrophoresis and double immunodiffusion. Antibodies were obtained from Behringwerke AG Marburg and plasma or lipoprotein fractions were concentrated four-to five-fold to improve detection. These experiments failed to reveal the presence of apoB in the proband and efforts were made to concentrate the d <1 .063 g/ml lipoprotein fraction further before polyacrylamide gel electrophoresisl3 or electroimmunophoresis using the Laurell technique.14 Specifically, 50 ml of blood was collected into tubes containing EDTA (1 mg/ml blood) and centrifuged immediately to obtain the plasma to which the following preservatives were then added: penicillin 30 mg/100 ml, streptomycin 5 mg/100 ml, dithiothreitol 50 mg/100 ml, sodium azide 20 mg/100 ml, phenylmethylsulfonyl fluoride 0.6 mmol/l, and E-aminocaproic acid 130 mg/100 ml.
A total of 25 ml of plasma was over-layered with KBr 20 g/100 ml glycerol and 5 g/100 ml B-mercaptoethanol); 80 ,lI of the mixture was applied to a polyacrylamide gradient gel and electrophoresed at 70 V for 16 hours. The above procedure was performed on two separate samples of plasma with an intervening interval of 6 months. Great care was taken to ensure that no extraneous apoB contamination occurred, especially on the second occasion. The final aliquot applied thus represented the total apolipoprotein content of the d <1 -063 g/ml LP fraction from 11 ml plasma, ignoring non-specific losses incurred during the procedure. The same lipoprotein fraction obtained, after previous removal of chylomicrons, from 4 ml plasma from non-fasting, normolipaemic control subjects was isolated using essentially similar procedures. The amount of apolipoprotein, however, finally applied to the gel represented that derived from only 5-6 [LI of the original plasma. For purposes of immunochemical detection the d < 1 .063 fraction was isolated by ultracentrifugation as above, but without washing. The six times concentrated ultracentrifugal fraction was dialysed overnight against Tris-HCl, pH 7.4, and an aliquot was concentrated a further 34-fold by means of ultrafiltration and dialysis (MicroProDiCon, Bio-Molecular Dynamics, Oregon). Of this, 3 ,ul were applied directly to the well of an agarose gel plate (108 ,ul of apoB antiserum in 15 ml of 0* 75 % agarose gel). Since we usually dilute whole plasma 15-fold for apoB assay by electroimmunophoresis, the d <1.063 fraction from the proband was therefore concentrated 3060 times (6 x 34 x 15) relative to normal plasma. To check specificity, 1 080<d<1.25 lipoprotein fractions from the proband and from a normal control were also run. The sensitivity was ascertained by diluting a d <1 063 lipoprotein fraction of normal plasma 1200 times and 2400 times before being processed in the same way as plasma from the proband. Small 'rockets' were seen with both these dilutions whereas the 1 080 <d<1 .25 fraction from a normal subject failed to react with antiserum.
The viscosity of whole blood and plasma was determined by means of whole blood, corrected for haematocrit, was 7.35 cps at the age of 8 years. A reference range derived from 15 healthy aduLlt subjects was 4-25 to 6-75 cps. Increased microviscosity of red cell membranes in abetalipoproteinaemic subjects has previously been reported.15 Whole blood viscosity in the mother of the proband was normal (5 66 cps).
The patient's neurological and ophthalmological status was completely normal on careful clinical examination at the time of diagnosis and when last determined at the age of 9 years. Her peroneal nerve conduction rate (53 m/s) and terminal latency period (2-05 m/s) were also within normal levels at the age of 5 years, and at the age of 6.3 years her electroretinogram, visual evoked responses, and visual acuity were completely normal. The recurrent respiratory infections have ceased but growth has remained severely retarded (<3rd centile). Discussion
The trait for hypobetalipoproteinaemia in this kindred is vertically transmitted through three maternal generations (fig 1) , culminating in apparent abetalipoproteinaemia in the proband. All Despite our negative findings, using relatively insensitive methods, and the failure of previous workers to detect apoB using comparable or more sensitive techniques, on polyacrylamide electrophoresis of a highly concentrated plasma fraction from the proband, we were able to visualise clearly a protein band co-migrating with normal apoB. In the procedure we finally adopted, the apolipoproteins derived from an approximately 2000-fold greater volume of plasma from the proband than from the control subject were applied to the gel (see Methods). Despite this discrepancy, visualisation of the stained bands ( fig 4) revealed a two-fold greater intensity of the apoB band in the control strips. These observations imply that the concentration of apoB in the proband's plasma was about 0.025 % of normal, or 0.02 mg/100 ml assuming a normal plasma apoB concentration of 80 mg/100 ml. 18 The electrophoretic results were corroborated by detecting small, but definite, amounts of apoB immunoreactivity in a highly concentrated d < 1 .063 lipoprotein fraction from the proband (fig 5) . The presence of some apoB in the HDL (1 .080 <d <1 -25) fraction obtained from the proband was surprising, but could not be attributed to non-specificity since no reaction was seen using concentrated HDL from a healthy control. Since, by the time this analysis was performed, the d >1 -063 g/ml fraction from the proband had stood at +40 for more than 4 weeks, the possibility of contamination cannot be ruled out.
Recently a number of distinct apoB isoproteins have been found in plasma from rats'9 and humans.20 Kane et 
